Millions of healthy Americans take daily supplements that federal research agencies say provide no measurable benefit and, in some cases, carry real clinical risks. An NIH analysis of approximately 390,000 U.S. adults found no link between routine multivitamin use and lower mortality. A large randomized trial showed vitamin D3 at 2,000 IU per day did not reduce fracture risk in midlife and older adults without known deficiency. The FDA has flagged biotin supplements for interfering with troponin lab tests used to detect heart damage. Taken together, the evidence points to a growing disconnect between what supplement marketing promises and what controlled studies actually deliver.
Why supplement spending outpaces the science
The gap between advertising claims and clinical evidence keeps widening. Supplement companies market directly to consumers with language that implies broad health protection, yet the largest government-backed studies consistently fail to find those benefits in people who already eat a reasonably balanced diet. The U.S. Preventive Services Task Force has gone further, explicitly recommending against beta-carotene and vitamin E supplements for the prevention of cancer or cardiovascular disease, according to the federal integrative health agency.
National dietary surveys show that most adults in the United States meet their basic nutrient needs through food alone. When a person without a diagnosed deficiency adds a daily pill, the body typically excretes what it does not need or, worse, the supplement creates downstream problems that neither the consumer nor their doctor anticipated. The persistence of supplement use among healthy adults tracks more closely with direct-to-consumer advertising spend than with any documented nutrient shortfall in population-level health data.
Marketing also exploits a simple psychological bias: doing something feels safer than doing nothing. A pill becomes an easy, relatively inexpensive way to feel proactive about health, even when the underlying behaviors that drive long-term outcomes-diet quality, physical activity, sleep, and avoidance of tobacco-are far more powerful. Because supplements are sold over the counter and labeled as “dietary” rather than “drugs,” many people assume they are automatically safe and at least modestly helpful. The science does not always cooperate with that assumption.
What the VITAL trial and NIH cohort data actually show
Two of the strongest pieces of evidence come from federally supported research programs. The VITAL randomized controlled trial enrolled generally healthy midlife and older adults who were not selected for vitamin D deficiency or osteoporosis. Participants received either 2,000 IU of vitamin D3 daily or a placebo. The result was clear: high-dose vitamin D did not significantly reduce fractures compared with placebo. For the millions of people taking vitamin D “just in case,” this trial offers the most direct test of that assumption, and the assumption failed.
A separate analysis examined approximately 390,000 U.S. adults over an extended follow-up period. The finding, summarized in an NIH communication, was blunt: regular multivitamin use was not associated with a lower risk of death. The study used peer-reviewed methods and a large enough sample to detect even modest mortality differences. None appeared. For healthy adults without specific deficiencies, the daily multivitamin offered no survival advantage over skipping it entirely.
Antioxidant supplements tell a similar story. Vitamins C and E, beta-carotene, and other antioxidant pills were once expected to prevent cancer and heart disease by neutralizing cell-damaging free radicals. That theory has not held up in clinical trials. The NIH National Center for Complementary and Integrative Health reports that antioxidant supplements have not shown the expected prevention benefits for cancer or cardiovascular disease. In some trials, beta-carotene supplementation was linked to increased lung cancer risk in smokers, which is the opposite of what proponents predicted.
Biotin, widely sold for hair and nail health, presents a different kind of risk. The supplement does not just fail to help most healthy people; it actively interferes with diagnostic accuracy. The FDA maintains a list of troponin assays subject to biotin-related interference. Troponin is the blood marker doctors rely on to confirm or rule out a heart attack. If a patient taking high-dose biotin arrives at an emergency room with chest pain, the lab result could read falsely low, potentially masking cardiac damage. That is not a theoretical concern. The FDA has formally documented the interference and warned clinicians and patients about it.
Six supplements and the evidence against routine use
Based on the available federal research, six categories of supplements stand out as unnecessary for most healthy adults:
- Daily multivitamins, which showed no mortality benefit in a cohort of approximately 390,000 people.
- Vitamin D supplements for adults without a diagnosed deficiency, given the VITAL trial’s null result on fracture prevention.
- Vitamin E for cancer or heart disease prevention, which the USPSTF recommends against.
- Beta-carotene supplements for the same preventive purposes, also flagged by the USPSTF.
- Biotin at supplemental doses, which can distort critical cardiac lab tests.
- Broad antioxidant blends marketed for disease prevention, which have repeatedly failed to deliver in controlled trials.
Each of these products remains legal to sell and easy to buy. Supplements do not require FDA approval before reaching store shelves, and marketing claims fall under a looser structure-function standard rather than the rigorous efficacy requirements applied to prescription drugs. As long as labels avoid explicitly promising to “treat” or “cure” disease, companies can imply wide-ranging benefits with relatively little oversight.
That regulatory gap puts more responsibility on consumers and clinicians to sort hype from evidence. For people with documented deficiencies, malabsorption disorders, or specific medical indications, targeted supplementation can be appropriate and sometimes essential. The research cited here does not argue against medically supervised use in those contexts. Instead, it challenges the routine, unsupervised use of multivitamins, high-dose vitamin D, antioxidant cocktails, and biotin in otherwise healthy adults who already meet their nutrient needs through food.
For most people, the safer and more effective strategy is to focus on proven health fundamentals: eating a varied diet rich in fruits, vegetables, whole grains, and lean proteins; staying physically active; not smoking; and getting recommended preventive care. These steps have a far stronger evidence base for extending life and reducing disease risk than any over-the-counter supplement marketed to the general public. Until supplement claims catch up with large, well-controlled trials, the science suggests that many healthy adults could close their pill bottles without sacrificing health-and, in some cases, might avoid hidden risks by doing so.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
